EC-1456

N/A

Report date: 2023/08/28 20:00:45
NME

Base Information

Drug NameEC-1456
Drug Alias NameFolate-tubulysinFolate-targeted tubulysin-EndocyteFolic acid-tubulysin conjugate (EC1456) - EndocyteEC-1456EC-0531
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitorsFolate receptor alpha antagonistsMitosis inhibitors
TargetsFolate receptor alphaTubulin
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndocyte Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A